Carbiotix AB (publ) (NGM:CRBX)

Market Cap	35.13M
Revenue (ttm)	2.11M
Net Income (ttm)	-15.39M
Shares Out	4.98M
EPS (ttm)	-2.94
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,648
Average Volume	18,932
Open	6.98
Previous Close	7.06
Day's Range	6.50 - 6.98
52-Week Range	3.70 - 19.00
Beta	0.62
RSI	49.69
Earnings Date	Nov 5, 2025

About Carbiotix AB

Carbiotix AB (publ), a biotechnology company develops health testing and microbiome modulators to address a range of chronic and metabolic diseases. Its portfolio includes prebiotic ingredients and diagnostic testing services. The company develops CarbiAXOS, a second-generation prebiotic soluble fiber based on virgin and upcycled natural substrates containing arabinoxylo-oligosaccharides that is customized to meet customer needs to the production of short chain fatty acids or any other effect; and LinkGut, a health test. Carbiotix AB (publ) was...

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2014
• Employees: 8
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: CRBX

Financial Performance

In 2024, Carbiotix AB's revenue was 2.86 million, a decrease of -33.38% compared to the previous year's 4.29 million. Losses were -16.13 million, 19.7% more than in 2023.